Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-03-27

FDA Approved: TIVICAY — Supplemental Application (ViiV Healthcare Company)

View source ↗

Summary

The FDA approved a supplemental application for Tivicay (dolutegravir) submitted by ViiV Healthcare Company. This action updates the regulatory status of Tivica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tivicay (dolutegravir)

Snippet

SUPPL AP for TIVICAY (DOLUTEGRAVIR SODIUM)